To include your compound in the COVID-19 Resource Center, submit it here.

MT 100: Phase III

In a U.S. Phase III trial of 1,000 migraine patients, MT 100 was well

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE